Response

To the Editor:
We thank Dr Nair for his pertinent comments concerning the use of fl uorodeoxyglucose (FDG)-PET scanning in the evaluation of pleural disease. As we made clear in our description of a case of pleural disease associated with ankylosing spondylities (AS) recently published in CHEST (October 2010), 1 FDG-PET scan-avid pleural lesions only denote increased metabolic activity within the area of interest but do not provide specifi c information concerning the source of that activity, which may be neoplastic or infl ammatory. 2 As is true for many imaging modalities, on some occasions the clinical scenario and/or radiographic appearance are such that a specifi c nonmalignant diagnosis can be made with enough confi dence to obviate the need for an invasive procedure. Clearly, in our patient with a history of tobacco use and possible asbestos exposure it was mandatory that a fi rm, histologic diagnosis be pursued.
Nevertheless, we believe it is important to remind clinicians that FDG-PET scan avidity has been demonstrated in a wide variety of infl ammatory disorders affecting the lungs and pleura, including infection as well as noninfectious granulomatous disease, such as those produced by talc pleurodesis or due to sarcoidosis. 3 , 4 However, the appearance of pleural disease asso ciated with collagen vascular disorders on FDG-PET scan has only rarely been reported. Rheumatoid arthritis with FDG-PET scan-avid pleural involvement has been described in only one previous report. 5 Spinal lesions with FDG-PET scan avidity are known to occur in patients with AS, 6 but it appears that our case is the fi rst to describe FDG-PET scan positivity in pleural disease due to AS.
Silicosis: Hidden Behind TB?
To the Editor:
We read with great interest the case report of a 53-year-old man with dysphagia, anorexia, and night sweats by Ferguson and Schwarz in a recent issue of CHEST (November 2010). 1 We believe a few issues need to be addressed after going through this report.
Although a diagnosis of TB was confi rmed on sputum cultures, coexistence of a concomitant pneumoconiosis (eg, silicosis in this case) cannot be ruled out because there is a history of exposure to the cement industry. Silicotuberculosis is a well-described entity in literature, and it is said that silicosis increases the predisposition toward TB. 2 The parenchymal nodules on chest radiograph and diffuse miliary pattern with mediastinal lymphadenopathy on CT scan described in this patient can be associated with silicosis. 3 In this patient, the miliary shadows could be present because of preexist ing silicosis and right upper lobe infi ltrate because of superadded TB infection. Flexible bronchoscopy (transbronchial lung biopsy and BAL) or, preferably, open lung biopsy might have helped to rule out concomitant silicosis in this case. 4 Patients with silicotuberculosis may have resistance to antitubercular medications, and they may need a longer duration of treatment as compared with TB alone 5 ; hence, it is important to recognize concomitant silicosis in the context of this case report.
Pleuritic chest pain and pericardial effusion on echocardiogram suggest the diagnosis of pericardial TB, but the authors did not mention this in their fi nal diagnosis. Moreover, steroids should have been added for treatment of pericardial TB in addition to standard anti-TB regimen. 6 
